Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| RAFFEL KEITH | SVP & Chief Commercial Officer | 3 | $0 | $0 | 2013-03-18 |
| Shuster Lewis | Director | 10 | $0 | $0 | 2013-03-18 |
| BANSAL AJAY | SVP & Chief Financial Officer | 5 | $0 | $0 | 2013-03-18 |
| HOMAN ARTHUR W | SVP, Gen. Counsel & Secretary | 2 | $0 | $0 | 2013-03-18 |
| CASKEY C THOMAS | Director | 12 | $0 | $0 | 2013-03-18 |
| WALL ROBERT T | Director | 8 | $0 | $0 | 2013-03-18 |
| OVP VENTURE PARTNERS VI LP | 10% Owner | 9 | $0 | $3.11M | 2013-03-18 |
| WAITE CHARLES P JR | Director, 10% Owner | 16 | $0 | $3.11M | 2013-03-18 |
| REID CLIFFORD A | President & CEO | 7 | $0 | $0 | 2013-03-18 |
| DRMANAC RADOJE T | Chief Scientific Officer | 9 | $0 | $0 | 2013-03-18 |
| ORBIMED ADVISORS LLC | 10% Owner | 6 | $0 | $3.31M | 2012-07-13 |
| SENYEI ANDREW E | Director, 10% Owner | 2 | $0 | $0 | 2012-06-22 |
| Martin Bruce K | SVP, Product Development | 2 | $0 | $0 | 2012-04-02 |
| Sutherland Mark J. | SVP, Business Development | 1 | $0 | $0 | 2011-04-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| BANSAL AJAY | SVP & Chief Financial Office | D To issuer deriv | 2013-03-18 | 2013-03-18 | 50,000 | $0.14 | $7.0K | 0 | SEC↗ |
| BANSAL AJAY | SVP & Chief Financial Office | D To issuer deriv | 2013-03-18 | 2013-03-18 | 128,000 | $0.46 | $58.9K | 0 | SEC↗ |
| CASKEY C THOMAS | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 10,000 | $0.72 | $7.2K | 0 | SEC↗ |
| CASKEY C THOMAS | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 8,000 | $1.24 | $9.9K | 0 | SEC↗ |
| CASKEY C THOMAS | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 834 | $3.15 | $2.6K | 0 | SEC↗ |
| CASKEY C THOMAS | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 4,000 | $3.15 | $12.6K | 0 | SEC↗ |
| CASKEY C THOMAS | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 247 | $2.83 | $699 | 0 | SEC↗ |
| CASKEY C THOMAS | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 5 | $2.86 | $14 | 0 | SEC↗ |
| CASKEY C THOMAS | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 2,500 | $0.46 | $1.1K | 0 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | D To issuer deriv | 2013-03-18 | 2013-03-18 | 36,666 | $1.65 | $60.5K | 0 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | D To issuer deriv | 2013-03-18 | 2013-03-18 | 50,000 | $0.14 | $7.0K | 0 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | D To issuer deriv | 2013-03-18 | 2013-03-18 | 168,501 | $1.65 | $278.0K | 0 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | D To issuer deriv | 2013-03-18 | 2013-03-18 | 2,864 | $1.65 | $4.7K | 0 | SEC↗ |
| HOMAN ARTHUR W | SVP, Gen. Counsel & Secretar | D To issuer deriv | 2013-03-18 | 2013-03-18 | 100,000 | $0.14 | $14.0K | 0 | SEC↗ |
| RAFFEL KEITH | SVP & Chief Commercial Offic | D To issuer deriv | 2013-03-18 | 2013-03-18 | 50,000 | $0.14 | $7.0K | 0 | SEC↗ |
| REID CLIFFORD A | President & CEO | D To issuer deriv | 2013-03-18 | 2013-03-18 | 3,090 | $1.65 | $5.1K | 0 | SEC↗ |
| REID CLIFFORD A | President & CEO | D To issuer deriv | 2013-03-18 | 2013-03-18 | 341,667 | $1.65 | $563.8K | 0 | SEC↗ |
| REID CLIFFORD A | President & CEO | D To issuer deriv | 2013-03-18 | 2013-03-18 | 250,000 | $0.14 | $35.0K | 0 | SEC↗ |
| REID CLIFFORD A | President & CEO | D To issuer deriv | 2013-03-18 | 2013-03-18 | 50,666 | $1.65 | $83.6K | 0 | SEC↗ |
| Shuster Lewis | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 8,000 | $1.24 | $9.9K | 0 | SEC↗ |
| Shuster Lewis | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 10,000 | $0.72 | $7.2K | 0 | SEC↗ |
| Shuster Lewis | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 2,500 | $0.46 | $1.1K | 0 | SEC↗ |
| Shuster Lewis | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 4,000 | $3.15 | $12.6K | 0 | SEC↗ |
| Shuster Lewis | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 834 | $3.15 | $2.6K | 0 | SEC↗ |
| WALL ROBERT T | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 4,000 | $3.15 | $12.6K | 0 | SEC↗ |
| WALL ROBERT T | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 834 | $3.15 | $2.6K | 0 | SEC↗ |
| WALL ROBERT T | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 8,000 | $1.24 | $9.9K | 0 | SEC↗ |
| WAITE CHARLES P JR | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 1,667 | $3.15 | $5.3K | 0 | SEC↗ |
| WAITE CHARLES P JR | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 8,000 | $1.24 | $9.9K | 0 | SEC↗ |
| WAITE CHARLES P JR | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 4,000 | $3.15 | $12.6K | 0 | SEC↗ |
| WAITE CHARLES P JR | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 135,939 | $2.82 | $383.3K | 0 | SEC↗ |
| WAITE CHARLES P JR | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 52,735 | $2.85 | $150.3K | 0 | SEC↗ |
| WAITE CHARLES P JR | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 2,282 | $2.82 | $6.4K | 0 | SEC↗ |
| WAITE CHARLES P JR | Director | D To issuer deriv | 2013-03-18 | 2013-03-18 | 885 | $2.85 | $2.5K | 0 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | D To issuer deriv | 2013-03-18 | 2013-03-18 | 52,735 | $2.85 | $150.3K | 0 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | D To issuer deriv | 2013-03-18 | 2013-03-18 | 135,939 | $2.82 | $383.3K | 0 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | D To issuer deriv | 2013-03-18 | 2013-03-18 | 885 | $2.85 | $2.5K | 0 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | D To issuer deriv | 2013-03-18 | 2013-03-18 | 2,282 | $2.82 | $6.4K | 0 | SEC↗ |
| BANSAL AJAY | SVP & Chief Financial Office | D To issuer | 2013-03-14 | 2013-03-18 | 1,696 | $3.15 | $5.3K | 0 | SEC↗ |
| CASKEY C THOMAS | Director | D To issuer | 2013-03-14 | 2013-03-18 | 6,817 | $3.15 | $21.5K | 0 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | D To issuer | 2013-03-14 | 2013-03-18 | 131,999 | $3.15 | $415.8K | 0 | SEC↗ |
| RAFFEL KEITH | SVP & Chief Commercial Offic | D To issuer | 2013-03-14 | 2013-03-18 | 13,000 | $3.15 | $41.0K | 0 | SEC↗ |
| REID CLIFFORD A | President & CEO | D To issuer | 2013-03-14 | 2013-03-18 | 310,200 | $3.15 | $977.1K | 0 | SEC↗ |
| Shuster Lewis | Director | D To issuer | 2013-03-14 | 2013-03-18 | 1,666 | $3.15 | $5.2K | 0 | SEC↗ |
| WALL ROBERT T | Director | D To issuer | 2013-03-14 | 2013-03-18 | 51,666 | $3.15 | $162.7K | 0 | SEC↗ |
| WAITE CHARLES P JR | Director | D To issuer | 2013-03-14 | 2013-03-18 | 1,427,962 | $3.15 | $4.50M | 0 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | U Tender | 2013-03-14 | 2013-03-18 | 1,424,629 | $3.15 | $4.49M | 0 | SEC↗ |
| WALL ROBERT T | Director | M Exercise deriv | 2012-11-30 | 2012-12-03 | 833 | — | $0 | 834 | SEC↗ |
| WAITE CHARLES P JR | Director, 10% Owner | M Exercise deriv | 2012-11-30 | 2012-12-03 | 1,667 | — | $0 | 1,667 | SEC↗ |
| Shuster Lewis | Director | M Exercise deriv | 2012-11-30 | 2012-12-03 | 833 | — | $0 | 834 | SEC↗ |
| CASKEY C THOMAS | Director | M Exercise deriv | 2012-11-30 | 2012-12-03 | 833 | — | $0 | 834 | SEC↗ |
| WALL ROBERT T | Director | M Exercise | 2012-11-30 | 2012-12-03 | 833 | — | $0 | 1,666 | SEC↗ |
| WAITE CHARLES P JR | Director, 10% Owner | M Exercise | 2012-11-30 | 2012-12-03 | 1,667 | — | $0 | 3,333 | SEC↗ |
| Shuster Lewis | Director | M Exercise | 2012-11-30 | 2012-12-03 | 833 | — | $0 | 1,666 | SEC↗ |
| CASKEY C THOMAS | Director | M Exercise | 2012-11-30 | 2012-12-03 | 833 | — | $0 | 6,817 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2012-07-13 | 2012-07-13 | 4,500 | $2.51 | $11.3K | 27,859 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2012-07-13 | 2012-07-13 | 474,800 | $2.51 | $1.19M | 2,922,141 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2012-07-12 | 2012-07-13 | 2,076 | $2.85 | $5.9K | 32,359 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2012-07-12 | 2012-07-13 | 218,624 | $2.85 | $623.1K | 3,396,941 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2012-07-11 | 2012-07-13 | 4,792 | $2.90 | $13.9K | 34,435 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2012-07-11 | 2012-07-13 | 503,144 | $2.90 | $1.46M | 3,615,565 | SEC↗ |
| WALL ROBERT T | Director | A Award deriv | 2012-06-22 | 2012-06-26 | 8,000 | — | $0 | 8,000 | SEC↗ |
| WALL ROBERT T | Director | A Award deriv | 2012-06-22 | 2012-06-26 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Shuster Lewis | Director | A Award deriv | 2012-06-22 | 2012-06-26 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Shuster Lewis | Director | A Award deriv | 2012-06-22 | 2012-06-26 | 4,000 | — | $0 | 4,000 | SEC↗ |
| WAITE CHARLES P JR | Director, 10% Owner | A Award deriv | 2012-06-22 | 2012-06-26 | 4,000 | — | $0 | 4,000 | SEC↗ |
| WAITE CHARLES P JR | Director, 10% Owner | A Award deriv | 2012-06-22 | 2012-06-26 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CASKEY C THOMAS | Director | A Award deriv | 2012-06-22 | 2012-06-26 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CASKEY C THOMAS | Director | A Award deriv | 2012-06-22 | 2012-06-26 | 4,000 | — | $0 | 4,000 | SEC↗ |
| SENYEI ANDREW E | Director, 10% Owner | A Award deriv | 2012-06-22 | 2012-06-26 | 8,000 | — | $0 | 8,000 | SEC↗ |
| SENYEI ANDREW E | Director, 10% Owner | A Award deriv | 2012-06-22 | 2012-06-26 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RAFFEL KEITH | SVP & Chief Commercial Offic | A Award deriv | 2012-04-02 | 2012-04-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Martin Bruce K | SVP, Product Development | A Award deriv | 2012-04-02 | 2012-04-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | A Award deriv | 2012-04-02 | 2012-04-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BANSAL AJAY | SVP & Chief Financial Office | A Award deriv | 2012-04-02 | 2012-04-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| REID CLIFFORD A | President & CEO | A Award deriv | 2012-04-02 | 2012-04-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| HOMAN ARTHUR W | SVP & General Counsel | A Award deriv | 2012-04-02 | 2012-04-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| WAITE CHARLES P JR | Director, 10% Owner | S Sale | 2012-03-16 | 2012-03-16 | 450,000 | $2.92 | $1.31M | 1,392,550 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | S Sale | 2012-03-16 | 2012-03-16 | 450,000 | $2.92 | $1.31M | 1,392,550 | SEC↗ |
| WAITE CHARLES P JR | Director, 10% Owner | S Sale | 2012-03-15 | 2012-03-16 | 165,059 | $2.89 | $477.0K | 1,842,550 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | S Sale | 2012-03-15 | 2012-03-16 | 165,059 | $2.89 | $477.0K | 1,842,550 | SEC↗ |
| WAITE CHARLES P JR | Director, 10% Owner | S Sale | 2012-03-14 | 2012-03-16 | 142,941 | $3.09 | $441.7K | 2,007,609 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | S Sale | 2012-03-14 | 2012-03-16 | 142,941 | $3.09 | $441.7K | 2,007,609 | SEC↗ |
| WAITE CHARLES P JR | Director, 10% Owner | S Sale | 2012-03-13 | 2012-03-15 | 275,000 | $3.20 | $880.0K | 2,150,550 | SEC↗ |
| OVP VENTURE PARTNERS VI LP | 10% Owner | S Sale | 2012-03-13 | 2012-03-15 | 275,000 | $3.20 | $880.0K | 2,150,550 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | D To issuer | 2012-02-13 | 2012-02-14 | 30,000 | $4.05 | $121.5K | 118,666 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | D To issuer | 2012-01-09 | 2012-01-11 | 20,000 | $4.00 | $80.0K | 148,666 | SEC↗ |
| REID CLIFFORD A | Chief Executive Officer | A Award deriv | 2011-04-11 | 2012-02-14 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BANSAL AJAY | Chief Financial Officer | A Award deriv | 2011-04-11 | 2012-02-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| DRMANAC RADOJE T | Chief Scientific Officer | A Award deriv | 2011-04-11 | 2012-02-14 | 84,000 | — | $0 | 84,000 | SEC↗ |
| Martin Bruce K | SVP, Product Development | A Award deriv | 2011-04-11 | 2012-02-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sutherland Mark J. | SVP, Business Development | A Award deriv | 2011-04-11 | 2012-02-14 | 51,000 | — | $0 | 51,000 | SEC↗ |